Advanced Biomed Common Stock Market Outlook
| ADVB Stock | 0.24 0.01 4.00% |
About 53% of Advanced Biomed's investor base is interested to short. The analysis of overall sentiment of trading Advanced Biomed Common stock suggests that many investors are impartial at this time. The current market sentiment, together with Advanced Biomed's historical and current headlines, can help investors time the market. In addition, many technical investors use Advanced Biomed Common stock news signals to limit their universe of possible portfolio assets.
Comfort Level 47
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Advanced Biomed's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Advanced Biomed Common.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Advanced Biomed Common is 'Strong Sell'. Macroaxis provides Advanced Biomed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ADVB positions.
Execute Advanced Biomed Advice
The Advanced recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Advanced Biomed Common. Macroaxis does not own or have any residual interests in Advanced Biomed Common or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Advanced Biomed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Risky | Details | |
Economic Sensitivity | Responds to the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Advanced Biomed Common has a Mean Deviation of 4.0, Standard Deviation of 5.41 and Variance of 29.23We provide trade advice to complement the prevailing expert consensus on Advanced Biomed Common. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Advanced Biomed is not overpriced, please confirm all Advanced Biomed Common fundamentals, including its total debt and the relationship between the short ratio and working capital . As Advanced Biomed Common appears to be a penny stock we also recommend to validate its total debt numbers.
Advanced Biomed Trading Alerts and Improvement Suggestions
| Advanced Biomed generated a negative expected return over the last 90 days | |
| Advanced Biomed has high historical volatility and very poor performance | |
| Advanced Biomed has some characteristics of a very speculative penny stock | |
| Advanced Biomed has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (101.52 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Advanced Biomed generates negative cash flow from operations | |
| Advanced Biomed has a frail financial position based on the latest SEC disclosures | |
| About 77.0% of the company shares are held by company insiders | |
| Latest headline from thelincolnianonline.com: Advanced Biomed Posts Quarterly Earnings Results |
Advanced Biomed Returns Distribution Density
The distribution of Advanced Biomed's historical returns is an attempt to chart the uncertainty of Advanced Biomed's future price movements. The chart of the probability distribution of Advanced Biomed daily returns describes the distribution of returns around its average expected value. We use Advanced Biomed Common price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Advanced Biomed returns is essential to provide solid investment analysis for Advanced Biomed.
| Mean Return | -0.66 | Value At Risk | -9.68 | Potential Upside | 8.11 | Standard Deviation | 5.41 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Advanced Biomed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Advanced Biomed Cash Flow Accounts
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 (projected) | ||
| Change In Cash | 4.7M | (2.2M) | (14.3K) | 19.0K | 17.1K | 16.3K | |
| Free Cash Flow | (2.1M) | (3.2M) | (2.2M) | (182.5K) | (209.8K) | (220.3K) | |
| Change In Working Capital | 1.5M | 253.7K | 256.3K | (90.7K) | (81.6K) | (77.5K) | |
| Begin Period Cash Flow | 65.9K | 4.8M | 2.6M | 80.4K | 92.4K | 87.8K | |
| Total Cashflows From Investing Activities | (1.1M) | (263.0K) | (74.1K) | (985.0) | (1.1K) | (1.2K) | |
| Depreciation | 126.6K | 365.2K | 399.6K | 10.7K | 12.3K | 11.7K | |
| Other Non Cash Items | 1.7M | 150.2K | (53.5K) | 2.9B | 3.4B | 3.5B | |
| Capital Expenditures | 1.3M | 212.5K | 74.1K | 985.0 | 886.5 | 842.18 | |
| Total Cash From Operating Activities | (741.5K) | (3.0M) | (2.1M) | (181.5K) | (163.3K) | (171.5K) | |
| Net Income | (4.0M) | (3.7M) | (2.8M) | (101.5K) | (116.8K) | (122.6K) | |
| Total Cash From Financing Activities | 6.1M | 458.1K | 1.9M | 184.9K | 166.4K | 158.1K | |
| End Period Cash Flow | 4.8M | 2.6M | 2.6M | 99.4K | 89.5K | 85.0K |
Advanced Biomed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Advanced Biomed or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Advanced Biomed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Advanced stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.75 | |
β | Beta against Dow Jones | 1.24 | |
σ | Overall volatility | 5.43 | |
Ir | Information ratio | -0.14 |
Advanced Biomed Volatility Alert
Advanced Biomed Common exhibits very low volatility with skewness of 0.05 and kurtosis of 0.83. Advanced Biomed Common is a potential penny stock. Although Advanced Biomed may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Advanced Biomed Common. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Advanced instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Advanced Biomed Fundamentals Vs Peers
Comparing Advanced Biomed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Advanced Biomed's direct or indirect competition across all of the common fundamentals between Advanced Biomed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Advanced Biomed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Advanced Biomed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Advanced Biomed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Advanced Biomed to competition |
| Fundamentals | Advanced Biomed | Peer Average |
| Return On Equity | -1.65 | -0.31 |
| Return On Asset | -0.35 | -0.14 |
| Current Valuation | 4.06 M | 16.62 B |
| Shares Outstanding | 27.29 M | 571.82 M |
| Shares Owned By Insiders | 77.20 % | 10.09 % |
| Shares Owned By Institutions | 0.97 % | 39.21 % |
| Number Of Shares Shorted | 88.63 K | 4.71 M |
| Price To Book | 2.23 X | 9.51 X |
| EBITDA | (90.81 K) | 3.9 B |
| Net Income | (101.52 K) | 570.98 M |
| Total Debt | 1.26 M | 5.32 B |
| Book Value Per Share | 0.14 X | 1.93 K |
| Cash Flow From Operations | (181.46 K) | 971.22 M |
| Short Ratio | 1.58 X | 4.00 X |
| Earnings Per Share | (0.17) X | 3.12 X |
| Number Of Employees | 31 | 18.84 K |
| Market Capitalization | 6.55 M | 19.03 B |
| Total Asset | 6.51 B | 29.47 B |
| Retained Earnings | (19.23 B) | 9.33 B |
| Working Capital | 318.65 K | 1.48 B |
| Net Asset | 6.51 B |
Advanced Biomed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Advanced . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Advanced Biomed Buy or Sell Advice
When is the right time to buy or sell Advanced Biomed Common? Buying financial instruments such as Advanced Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Advanced Biomed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Funds Thematic Idea Now
Money Funds
Funds or Etfs that invest most if their asset in companies from financial sector such as commercial banks, insurance companies, investment funds, and real estate. The Money Funds theme has 34 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Advanced Biomed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Advanced Biomed. If investors know Advanced will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Advanced Biomed assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Understanding Advanced Biomed Common requires distinguishing between market price and book value, where the latter reflects Advanced's accounting equity. The concept of intrinsic value - what Advanced Biomed's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Advanced Biomed's price substantially above or below its fundamental value.
Understanding that Advanced Biomed's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Advanced Biomed represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Advanced Biomed's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.